Suppr超能文献

间接细胞介导的淋巴细胞溶解的变异

Variation in indirect cell-mediated lympholysis.

作者信息

Ennulat N M, Tice D, Carpenter D, Hubbell C, Reinitz E R

机构信息

Department of Surgery, SUNY Health Science Center, Syracuse 13210.

出版信息

J Clin Lab Immunol. 1988 Feb;25(2):73-6.

PMID:2897472
Abstract

The ability of an allograft recipient to respond to donor mononuclear cells in an indirect cell-mediated lympholysis (ICML) assay is an in vitro correlate of allograft rejection, but the value of this correlation depends upon the assay's reliability. We had observed inconsistency in the cytotoxic response of normal human mononuclear cells (MNC) to the same allogeneic stimulator MNC when cytotoxicity was measured repeatedly on different occasions by micro-ICML. We, therefore, investigated the extent and reasons for this inconsistency. Method variation, determined by duplicate ICML of 18 stimulator: responder MNC, was not statistically significant. Variation in cytotoxicity over time was greater but still not statistically significant. The contribution to method variation of 51Cr release from 3 different sets of target cells, cultured and labeled in duplicate, was minimal (6.33%). We then asked if in vitro generation of effector MNC under laboratory conditions was a major cause of ICML variation. We tested this using a stable transplant's in vivo sensitized effector cells against donor MNC in a direct CML (DCML) and obtained consistent results. Finally, to gain an understanding of some of the factors which might influence the generation of in vitro cytotoxicity, we measured the frequencies of cell surface antigens (DR, TAC, transferrin, Leu 2 and 3) concomitantly with ICML on day 6 of culture. Statistical analysis of the results led us to conclude that the micro-ICML is reproducible. The magnitude of lysis depends upon activated target cells (TAC- and transferrin-positive) and an increase in the proportion of helper/inducer to cytotoxic/suppressor T-lymphocytes during effector cell generation.

摘要

在间接细胞介导的淋巴细胞溶解(ICML)试验中,同种异体移植受体对供体单个核细胞作出反应的能力是同种异体移植排斥反应的一种体外相关指标,但这种相关性的价值取决于该试验的可靠性。我们曾观察到,当通过微量ICML在不同时间重复测量细胞毒性时,正常人单个核细胞(MNC)对相同的同种异体刺激MNC的细胞毒性反应存在不一致性。因此,我们研究了这种不一致性的程度及原因。通过对18组刺激细胞与反应细胞MNC进行重复ICML测定所确定的方法差异无统计学意义。细胞毒性随时间的变化更大,但仍无统计学意义。来自3组不同靶细胞(进行了重复培养和标记)的51Cr释放对方法差异的贡献极小(6.33%)。然后我们询问在实验室条件下效应MNC的体外生成是否是ICML差异的主要原因。我们在直接细胞介导的淋巴细胞溶解(DCML)试验中使用稳定移植的体内致敏效应细胞针对供体MNC进行了测试,并获得了一致的结果。最后,为了了解可能影响体外细胞毒性生成的一些因素,我们在培养第6天与ICML同时测量了细胞表面抗原(DR、TAC、转铁蛋白、Leu 2和3)的频率。对结果的统计分析使我们得出结论,微量ICML是可重复的。溶解程度取决于活化的靶细胞(TAC和转铁蛋白阳性)以及效应细胞生成过程中辅助/诱导性T淋巴细胞与细胞毒性/抑制性T淋巴细胞比例的增加。

相似文献

10
Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity.
J Reprod Immunol. 2008 Jul;78(2):85-93. doi: 10.1016/j.jri.2007.11.002. Epub 2008 Feb 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验